Australia - English - Department of Health (Therapeutic Goods Administration)

moderna australia pty ltd - elasomeran, quantity: 0.05 mg/ml; davesomeran, quantity: 0.05 mg/ml - injection, suspension - excipient ingredients: 1,2-dimyristoyl-rac-glycero-3-methoxypolyethylene glycol-2000; distearoylphosphatidylcholine; heptadecan-9-yl 8-[2-hydroxyethyl-(6-oxo-6-undecoxyhexyl)amino]octanoate; sucrose; trometamol; cholesterol; trometamol hydrochloride; sodium acetate trihydrate; water for injections; glacial acetic acid - spikevax bivalent original/omicron ba.4-5 (elasomeran/davesomeran) covid-19 vaccine is indicated for:,as a booster dose for active immunisation to prevent coronavirus disease 2019 (covid-19) caused by sars-cov-2 in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19.,the use of this vaccine should be in accordance with official recommendations.

Singapore - English - HSA (Health Sciences Authority)

biontech pharmaceuticals asia pacific pte. ltd. - famtozinameran; tozinameran - injection - famtozinameran 15 μg/dose; tozinameran 15 μg/dose

Singapore - English - HSA (Health Sciences Authority)

biontech pharmaceuticals asia pacific pte. ltd. - famtozinameran; tozinameran - injection - famtozinameran 15 μg/dose; tozinameran 15 μg/dose